HealthcareNeurocrine upped to overweight by Piper, sees '568 as still viableBy Helitra.com·August 30, 2024·1 min read Neurocrine upped to overweight by Piper, sees ‘568 as still viable Source: SeekingalphaADVERTISEMENT ADVERTISEMENTNeurocrine overweight Piper sees upped viable Post navigation Previous storyCooperCompanies hits 52-week high on Q3 beat and guidanceNext storyNuvectis gains on FDA’s orphan drug designation for cancer therapy
Fitness · HealthcareThe 8 best hair growth products for women of 2027, tested by real womenNovember 14, 2026While men’s receding hairlines and balding crowns tend to steal the spotlight, more than 50% of women will experience hair loss. And for…
Fitness · Healthcare‘Looksmaxxing’ Promises Better Looks—but It Can Put Teen Boys at RiskNovember 14, 2026Key Takeaways Social media is exposing boys to harmful beauty standards that can hurt their mental and physical health. Boys need safe spaces…
Fitness · HealthcareI hit my goal weight on a GLP‑1 — what now?November 14, 2026After losing close to 60 pounds in 12 months on a GLP-1 medication, I knew my clothes had gotten looser. But nothing prepared…